Table 1.
Patient Characteristics
| Characteristic | Regimen | |||
|---|---|---|---|---|
|
| ||||
| Interval Secondary Cytoreduction (n = 216) | No Interval Secondary Cytoreduction (n = 208) | |||
|
|
|
|||
| No. of Patients | % | No. of Patients | % | |
| Age | ||||
| <40 years | 11 | 5.1 | 14 | 6.7 |
| 40–49 years | 42 | 19.4 | 38 | 18.3 |
| 50–59 years | 68 | 31.5 | 71 | 34.0 |
| 60–69 years | 60 | 27.8 | 59 | 28.2 |
| ≥70 years | 35 | 16.2 | 26 | 12.4 |
|
| ||||
| Race | ||||
| Black | 10 | 4.6 | 14 | 6.7 |
| White | 198 | 91.7 | 183 | 88.0 |
| Hispanic | 5 | 2.3 | 6 | 2.9 |
| Other | 3 | 1.4 | 5 | 2.4 |
|
| ||||
| Performance status | ||||
| 0 | 83 | 38.4 | 83 | 39.7 |
| 1 | 119 | 55.1 | 108 | 51.9 |
| 2 | 14 | 6.5 | 17 | 8.1 |
|
| ||||
| Cell type | ||||
| Serous adenocarcinoma | 165 | 76.4 | 159 | 76.4 |
| Endometrioid adenocarcinoma | 17 | 7.9 | 11 | 5.3 |
| Mixed epithelial | 20 | 9.3 | 17 | 8.2 |
| Other | 14 | 6.5 | 21 | 10.1 |
|
| ||||
| Measurable disease | 152 | 70.4 | 145 | 69.7 |
|
| ||||
| Stage | ||||
| III | 200 | 92.6 | 200 | 96.2 |
| IV | 16 | 7.4 | 8 | 3.8 |